Human Interleukin 1 Receptor Antagonist (IL1RN) Protein

Este producto es parte de IL1RN - Interleukin 1 Receptor Antagonist
Product Graph
1326€ (1 mg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Interleukin 1 Receptor Antagonist (IL1RN) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx060248
tested applications
SDS-PAGE

Description

Human IL-1R antagonist Protein is a recombinant Human protein.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Interleukin 1 Receptor Antagonist (IL1RN)
Host
E. coli
Origin
Human
Conjugation
Unconjugated
Observed MW
Molecular Weight: 22 kDa
Expression
Recombinant
Purity
> 95% (HPLC and SDS-PAGE)
Size 1
1 mg
Form
Lyophilized Reconstitute with sterile 18MΩ-cm H2O.
Tested Applications
SDS-PAGE
Buffer
10 mM phosphate buffer, 200 mM NaCl (pH 7.0). Does not contain preservatives.
Availability
Shipped within 5-10 working days.
Storage
Store at -20°C or -80°C for 2 years. After reconstituting, it can be stored at 4°C for a week, it is recommended to add 0.1% HSA or BSA for long term. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P18510
Gene ID
3557
OMIM
147679
Alias
IL-1ra,IL1RA,IL-1RA,IL-1F3,ICIL-1RA,IL1 inhibitor
Background
Protein IL1RN
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

IL1RN is a natural anti-inflammatory protein that inhibits the activity of interleukin-1α (IL1α) and interleukin-1β (IL1β) by competitively binding to the IL-1 receptor (IL1R) without triggering downstream signaling This inhibition prevents IL1-mediated activation of NF-κB and subsequent production of pro-inflammatory cytokines IL1RN plays a crucial role in balancing inflammation, protecting tissues from excessive immune responses, and maintaining homeostasis Deficiency or mutations in IL1RN lead to autoinflammatory diseases, such as deficiency of IL1RN (DIRA), characterized by systemic inflammation and tissue damage IL1RN-based therapies, like anakinra, are used for treating rheumatoid arthritis, gout, and cryopyrin-associated periodic syndromes (CAPS), where IL1 overproduction drives disease progression

Related Products

FNab04244

IL1RN antibody

Ver Producto
abx001700

Interleukin 1 Receptor Antagonist (IL1RN) Antibody

IL1RN Antibody is a Rabbit Polyclonal antibody against IL1RN. The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Four alternatively spliced transcript variants encoding distinct isoforms have been reported.

Ver Producto
abx032831

Interleukin 1 Receptor Antagonist (IL1RN) Antibody

The protein is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses. A polymorphism of its gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer.

Ver Producto